Home › Psoriasis › Florida › Tampa
Psoriasis clinical trials in Tampa, FL
3 studies for Psoriasis are looking for participants at sites in and around Tampa (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
RecruitingPhase 4
- MOORE Clinical Research, Inc. d/b/a TrueBlue Clinical Research, Tampa
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
RecruitingPhase 3
- MOORE Clinical Research, Inc. d/b/a TrueBlue Clinical Research, Tampa
- USF Health, Tampa
A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
RecruitingPhase 2
- Study Center, Tampa
About Psoriasis
Psoriasis is a skin disease that causes itchy or sore patches of thick, red skin with silvery scales. Some people also get psoriasis arthritis.
More about Psoriasis on MedlinePlus
Psoriasis trials in other cities
- Trenton, NJ7 studies
- Philadelphia, PA6 studies
- Cleveland, OH6 studies
- Fremont, CA5 studies
- Huntington Beach, CA5 studies
- San Antonio, TX5 studies
- New York City, NY5 studies
- Newton, MA5 studies
- Houston, TX4 studies
- Birmingham, AL4 studies
- Sacramento, CA3 studies
- Miami, FL3 studies
Other studies in Tampa
- Non-Small Cell Lung Cancer53 studies
- Breast Cancer40 studies
- Cancer (all types)38 studies
- Colorectal Cancer36 studies
- Lung Cancer31 studies
- Metastatic Cancer30 studies
- Acute Myeloid Leukemia30 studies
- Pancreatic Cancer26 studies
- Melanoma21 studies
- Ovarian Cancer20 studies
- Alzheimer's Disease20 studies
- Myelodysplastic Syndromes20 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.